Skip to main content
OpenTrials
Completed

NCT Number: NCT06872450

Informational Tool for Smoking Cessation in COPD Patients

Chronic obstructive pulmonary disease (COPD) is a lung disease that affects nearly 8% of the adult population and causes 18,000 deaths per year in France. The most frequent cause of this pathology is smoking. COPD patients who stop smoking have a better quality of life, a marked a significant slowdown in disease progression and an increased life expectancy. Investigators propose to carry out a quantitative study among patients smokers suffering from COPD, by setting up a tool in the form of an motivational intervention specific to this population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Obstructive Pulmonary Disease (COPD) Chronic Disease Disease Attributes Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Nord Franche-comté

Trévenans, 90400, France

About this study

implementing a tool in the form of an informational intervention with a specific motivational intervention

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • People suffering from chronic obstructive pulmonary disease (COPD) stage 2/3
  • People treated at HNFC
  • Smokers

Exclusion criteria

  • People with cognitive disorders compromising comprehension and completion of the study

Treatment and study plan

Informational intervention

Other

informational intervention

Primary outcomes

  1. motivational effectiveness

    Time frame: 60 days

    Motivation to stop smoking (QMAT test)

  2. motivational effectiveness

    Time frame: 60 days

    Anxio-depressive state (HAD scale)

  3. motivational effectiveness

    Time frame: 60 days

    Degree of dependence (Fagerström test)

Sponsors and collaborators

Lead sponsor

Hopital Nord Franche-Comte

Other

Registry information

Official study title

Implementation and Impact Study of an Informational Tool for Smoking Cessation in COPD Patients

Acronym: IMPACT-BPCO

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Mar 12, 2025
Registry last updated
Aug 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.